[ad_1]
Indian Prime Minister Narendra Modi was inoculated with the first dose of a home-grown coronavirus vaccine on Monday, kicking off an expansion of the country’s immunization campaign that began in mid-January with healthcare workers.
People above 60, and those who are 45 or more and suffering from certain medical conditions, are now eligible for the vaccinations.
For more coronavirus news, visit our dedicated page.
India, which has reported the highest number of COVID-19 cases in the world after the US, has so far vaccinated more than 12 million health and front-line workers.
A woman walks past a painting of Indian Prime Minister Narendra Modi a day before the inauguration of the COVID-19 vaccination drive on a street in Mumbai, India, on January 15, 2021. (Reuters)
“Remarkable how our doctors and scientists have worked in quick time to strengthen the global fight against COVID-19,” Modi said on Twitter, posting a picture of him getting the shot at a government hospital in New Delhi.
“I appeal to all those who are eligible to take the vaccine. Together, let us make India COVID-19 free!”
Took my first dose of the COVID-19 vaccine at AIIMS.
Remarkable how our doctors and scientists have worked in quick time to strengthen the global fight against COVID-19.
I appeal to all those who are eligible to take the vaccine. Together, let us make India COVID-19 free! pic.twitter.com/5z5cvAoMrv
— Narendra Modi (@narendramodi) March 1, 2021
The government said last week it would let people choose their vaccination centers, effectively letting beneficiaries pick either the home-grown COVAXIN shot or the AstraZeneca vaccine, unlike earlier.
The inoculation campaign has progressed slower than expected due to a reluctance of health and front-line workers to take COVAXIN, which was approved without late-stage efficacy data. Only about 11 percent of vaccinated people have opted for the product developed by Bharat Biotech and the state-run Indian Council of Medical Research.
For all the latest headlines follow our Google News channel online or via the app.
Bharat Biotech has said efficacy data from a late-stage trial on nearly 26,000 volunteers who took COVAXIN will be out soon. The company, along with India’s drug regulator, says COVAXIN is safe and effective, based on early and intermediate studies.
India has reported more than 11 million coronavirus infections and over 157,000 deaths.
Read more:
India will release more locally made COVID-19 vaccines: PM Modi
India self-reliant on coronavirus vaccines, says PM Modi, as 1 mln inoculated
Coronavirus puzzling decline in India sparks a shopping spree
[ad_2]
Source link
